S23F (p.Ser23Phe) variant of HTR2C (5-hydroxytryptamine receptor 2C)

S23F (p.Ser23Phe) in HTR2C (5-hydroxytryptamine receptor 2C) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.10 / 1. The record also includes population frequency data and structural context.

S23F (p.Ser23Phe) variant details